Common name
methylboronic acid
IUPAC name
methylboronic acid
SMILES
B(O)(O)C
Common name
methylboronic acid
IUPAC name
methylboronic acid
SMILES
B(O)(O)C
INCHI
InChI=1S/CH5BO2/c1-2(3)4/h3-4H,1H3
FORMULA
CH5BO2
Common name
methylboronic acid
IUPAC name
methylboronic acid
Molecular weight
59.860
clogP
-1.477
clogS
1.017
Frequency
0.0003
HBond Acceptor
2
HBond Donor
2
Total PolarSurface Area
40.46
Number of Rings
0
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD01829 | Ixazomib |
|
Antineoplastic Agents; Protease Inhibitors; Antineoplastic and Immunomodulating Agents; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | Ixazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. |
1 ,
1
